Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cancer Research

• Publication date

  2014-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1158/0008-5472.CAN-13-2033PMID 24599128PMCID PMC4172421
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk categories and refractory CLL in the era of chemoimmunotherapy.

  2012cited by this paper
• Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemia

  2012cited by this paper
• The B-cell receptor signaling pathway as a therapeutic target in CLL.

  2012cited by this paper
• Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia.

  2012cited by this paper
• ON 01910.Na Is Selectively Cytotoxic for Chronic Lymphocytic Leukemia Cells through a Dual Mechanism of Action Involving PI3K/AKT Inhibition and Induction of Oxidative Stress

  2012cited by this paper
• Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukemia

  2012influential reference
• A high throughput drug screen for Entamoeba histolytica identifies a new lead and target

  2012influential reference
• Susceptibility of Human Head and Neck Cancer Cells to Combined Inhibition of Glutathione and Thioredoxin Metabolism

  2012cited by this paper
• Repurposing approved and abandoned drugs for the treatment and prevention of cancer through public-private partnership.

  2012cited by this paper
• Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia.

  2012cited by this paper
• Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia.

  2012cited by this paper
• Simultaneous inhibition of glutathione- and thioredoxin-dependent metabolism is necessary to potentiate 17AAG-induced cancer cell killing via oxidative stress.

  2012cited by this paper
• Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90.

  2011cited by this paper
• Molecular targets of oxidative stress.

  2011cited by this paper
• Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress

  2011cited by this paper
• The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation

  2011cited by this paper
• Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy

  2011cited by this paper
• Update on therapy of chronic lymphocytic leukemia.

  2011cited by this paper
• Enhancement of Carboplatin-Mediated Lung Cancer Cell Killing by Simultaneous Disruption of Glutathione and Thioredoxin Metabolism

  2011cited by this paper
• Targeting the dynamic HSP90 complex in cancer

  2010cited by this paper
• Loss of thioredoxin reductase 1 renders tumors highly susceptible to pharmacologic glutathione deprivation.

  2010cited by this paper
• Arsenic trioxide and ascorbic acid demonstrate promising activity against primary human CLL cells in vitro.

  2010cited by this paper
• Role of CAAT/Enhancer Binding Protein Homologous Protein in Panobinostat-Mediated Potentiation of Bortezomib-Induced Lethal Endoplasmic Reticulum Stress in Mantle Cell Lymphoma Cells

  2010cited by this paper
• Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis

  2010influential reference
• Rapid Activation of Glutamate Cysteine Ligase following Oxidative Stress*

  2010cited by this paper
• From pathogenesis to treatment of chronic lymphocytic leukaemia

  2010cited by this paper
• Treatment with Panobinostat Induces Glucose-Regulated Protein 78 Acetylation and Endoplasmic Reticulum Stress in Breast Cancer Cells

  2010influential reference
• Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.

  2010cited by this paper
• Heat shock factors: integrators of cell stress, development and lifespan

  2010cited by this paper
• Nrf2 responses and the therapeutic selectivity of electrophilic compounds in chronic lymphocytic leukemia

  2010influential reference
• Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

  2009influential reference
• The microenvironment in mature B-cell malignancies: a target for new treatment strategies.

  2009cited by this paper
• Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion.

  2008cited by this paper
• HO-1 underlies resistance of AML cells to TNF-induced apoptosis.

  2008cited by this paper
• HDAC6 a new cellular stress surveillance factor

  2008cited by this paper
• Thiol Chemistry in Peroxidase Catalysis and Redox Signaling

  2008cited by this paper
• HDAC6 inhibition enhances 17-AAG--mediated abrogation of hsp90 chaperone function in human leukemia cells.

  2008cited by this paper
• Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism.

  2008cited by this paper
• HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates.

  2007cited by this paper
• IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response

  2007cited by this paper
• Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia.

  2006cited by this paper
• ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemia.

  2005cited by this paper
• The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress.

  2003influential reference
• Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents.

  2003cited by this paper
• Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression

  2002cited by this paper
• Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1.

  2000cited by this paper
• Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations.

  1999influential reference
• Activation and proliferation of follicular dendritic cell-like cells by activated T lymphocytes.

  1994cited by this paper
• Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

  1984cited by this paper

• New N-Heterocyclic Carbene Gold and Platinum Complexes with 1,3-Dialkyl-4-anisyl-5-(4-chlorophenyl)imidazol-2-ylidene Ligands for the Treatment of Esophageal Adenocarcinoma.

  2026cites this paper
• Auranofin, identified by FDA-approved drug library screening, inhibits HBs antigen secretion via lysosomal damage

  2026cites this paper
• Structural and Mechanistic Characterization of Mycobacterium tuberculosis TrxR Inhibition by Glutathione-Coated Gold Nanocluster

  2026cites this paper
• Searching for New Gold(I)-Based Complexes as Anticancer and/or Antiviral Agents

  2025cites this paper
• Synthesis and in vitro characterization of [198Au]Auranofin

  2025cites this paper
• Long-Term Treatment with Low-Level Arsenite Induces Aberrant Proliferation and Migration via Redox Rebalance in Human Urothelial Cells

  2025cites this paper
• Auranofin Induces ER Stress‐Mediated Apoptosis, and Its Combination With Bortezomib Elicits Paraptosis‐Like Cell Death in Malignant Canine Mammary Tumour Cells

  2025cites this paper
• Beyond gold: the chemoenhancing mechanism and therapeutic potential of auranofin in melanoma

  2025cites this paper
• Recharacterization of the Tumor Suppressive Mechanism of RSL3 Identifies the Selenoproteome as a Druggable Pathway in Colorectal Cancer.

  2025cites this paper
• Targeting thioredoxin reductase 1 by Andrographolide contributes to inducing ROS-mediated apoptosis in human NSCLC cells.

  2025cites this paper
• Inhibition of Thioredoxin-Reductase by Auranofin as a Pro-Oxidant Anticancer Strategy for Glioblastoma: In Vitro and In Vivo Studies

  2025cites this paper
• Auranofin resensitizes ferroptosis-resistant lung cancer cells to ferroptosis inducers.

  2025cites this paper
• Reactive oxygen species promotion drives auranofin’s antiviral activity against hepatitis E virus

  2025cites this paper
• Platinum‐Based Chemotherapeutics in the Modern Era: From Classical DNA‐Targeting Mechanisms to Next‐Generation Innovations in Cancer Therapy

  2025cites this paper
• Thioredoxin Reductase 1 inhibition triggers ferroptosis in KRAS-independent lung cancers

  2025cites this paper
• Ionizing Radiation Combined with Gold Complex Compounds Causes Apoptosis in Colorectal Cancer Cells by Increasing the Level of Caspase-3.

  2025cites this paper
• Mechanism of auranofin toxicity: Inhibition of tetrahydrobiopterin metabolism

  2025cites this paper
• Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy

  2025cites this paper
• Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers

  2025cites this paper
• Thioredoxin: a key factor in cold tumor formation and a promising biomarker for immunotherapy resistance in NSCLC

  2025cites this paper
• Metabolic Collapse in Pancreatic Cancer via Combined Inhibition of Lactate Export and Thioredoxin Reductase

  2025cites this paper
• Carbon–phosphorus stapled Au(i) anticancer agents via bisphosphine induced reductive elimination

  2024cites this paper
• Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia‐positive lymphoid leukemia to tyrosine kinase inhibitors

  2024cites this paper
• Pro-Oxidant Auranofin and Glutathione-Depleting Combination Unveils Synergistic Lethality in Glioblastoma Cells with Aberrant Epidermal Growth Factor Receptor Expression

  2024cites this paper
• UBA1 dysfunction in VEXAS and cancer

  2024cites this paper
• Recharacterization of RSL3 reveals that the selenoproteome is a druggable target in colorectal cancer

  2024cites this paper
• Small molecules for impairing endoplasmic reticulum in cancer.

  2024cites this paper
• Potential New Therapies “ROS-Based” in CLL: An Innovative Paradigm in the Induction of Tumor Cell Apoptosis

  2024cites this paper
• Erlotinib-Gold(I) Complex Induces Leukemia Cell DC Differentiation and Remodels the Immunosuppressive Microenvironment.

  2024cites this paper
• Strategies for the design of analogs of auranofin endowed with anticancer potential

  2024cites this paper
• Anticancer Activity of Metallodrugs and Metallizing Host Defense Peptides—Current Developments in Structure-Activity Relationship

  2024cites this paper
• The rheumatoid arthritis drug auranofin exerts potent anti-lymphoma effect by stimulating TXNRD-mediated ROS generation and inhibition of energy metabolism

  2024cites this paper
• The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity

  2024cites this paper
• A clinical prognostic model of oxidative stress-related genes linked to tumor immune cell infiltration and the prognosis of ovarian cancer patients

  2024cites this paper
• Auranofin Suppresses the Growth of Canine Mammary Tumour Cells and Induces Apoptosis via the PI3K/AKT Pathway.

  2024cites this paper
• Pristimerin inhibits thioredoxin reductase in the treatment of non-small cell lung cancer

  2024cites this paper
• Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects

  2024cites this paper
• Auranofin Induces Lethality Driven by Reactive Oxygen Species in High-Grade Serous Ovarian Cancer Cells

  2023cites this paper
• Molecular mechanisms and clinical implications of the gold drug auranofin

  2023cites this paper
• The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity

  2023cites this paper
• The Lung Microbiome in COPD and Lung Cancer: Exploring the Potential of Metal-Based Drugs

  2023cites this paper
• Organogold(III)-dithiocarbamate compounds and their coordination analogues as anti-tumor and anti-leishmanial metallodrugs.

  2023cites this paper
• Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers

  2023cites this paper
• 3D-Shaped Binders of Unfolded Proteins Inducing Cancer Cell-Specific Endoplasmic Reticulum Stress In Vitro and In Vivo.

  2023cites this paper
• The prognostic and therapeutic potential of HO-1 in leukemia and MDS

  2023cites this paper
• Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression

  2023cites this paper
• Anti-tumoural [NHC(thiolato)]Au(I) complexes derived from HIF-1α inhibitor AC1-004 target the mitochondrial redox system and show antiangiogenic effects in vivo.

  2023cites this paper
• Auranofin inhibits the occurrence of colorectal cancer by promoting mTOR-dependent autophagy and inhibiting epithelial-mesenchymal transformation

  2023cites this paper
• Highlights of New Strategies to Increase the Efficacy of Transition Metal Complexes for Cancer Treatments

  2022cites this paper
• A novel cyclic dinuclear gold(I) complex induces anticancer activity via an oxidative stress-mediated intrinsic apoptotic pathway in MDA-MB-231 cancer cells.

  2022cites this paper
• Modulation of Cellular Redox Parameters for Improving Therapeutic Responses in Multiple Myeloma

  2022cites this paper
• Deubiquitinase Inhibitors Impair Leukemic Cell Migration Through Cofilin Oxidation and Alteration of Actin Reorganization

  2022cites this paper
• PRKCI Mediates Radiosensitivity via the Hedgehog/GLI1 Pathway in Cervical Cancer

  2022cites this paper
• Targeted Drug Delivery for Chronic Lymphocytic Leukemia

  2022cites this paper
• Omics-based identification of an NRF2-related auranofin resistance signature in cancer: Insights into drug repurposing

  2022cites this paper
• Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model

  2022cites this paper
• Design, Synthesis, and Preclinical Activity in Ovarian Cancer Models of New Phosphanegold(I)-N-heterocyclic Carbene Complexes.

  2022cites this paper
• Revisiting the anticancer properties of phosphane(9-ribosylpurine-6-thiolato)gold(I) complexes and their 9H-purine precursors

  2022cites this paper
• The rheumatoid arthritis drug auranofin lowers leptin levels and exerts antidiabetic effects in obese mice.

  2022cites this paper
• The thioredoxin system: Balancing redox responses in immune cells and tumors

  2022cites this paper
• Looking at denitrosylation to understand the myogenesis gone awry theory of rhabdomyosarcoma.

  2022cites this paper
• Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model

  2022cites this paper
• Natural and synthetic compounds in Ovarian Cancer: a focus on NRF2/KEAP1 pathway.

  2022cites this paper
• Anti-Cancer Effects of Auranofin in Human Lung Cancer Cells by Increasing Intracellular ROS Levels and Depleting GSH Levels

  2022cites this paper
• Biotin-Targeted Au(I) Radiosensitizer for Cancer Synergistic Therapy by Intervening with Redox Homeostasis and Inducing Ferroptosis.

  2022cites this paper
• Novel Insights into Redox-Based Mechanisms for Auranofin-Induced Rapid Cancer Cell Death

  2022cites this paper
• Au4 cluster inhibits human thioredoxin reductase activity via specifically binding of Au to Cys189

  2022cites this paper
• Redox proteome analysis of auranofin exposed ovarian cancer cells (A2780)

  2022cites this paper
• Attomole-per Cell Atomic Mass Spectrometry Measurement of Platinum and Gold Drugs in Cultured Lung Cancer Cells

  2021cites this paper
• ER Stress and Unfolded Protein Response in Leukemia: Friend, Foe, or Both?

  2021cites this paper
• Drug Repurposing: An Avenue Toward Stress Medicine in Cancer Therapy

  2021cites this paper
• Synthesis, anticancer activity and apoptosis induction of gold(I) complexes containing tris(o-methoxyphenyl)phosphane

  2021cites this paper
• Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness

  2021cites this paper
• Auranofin and ICG-001 Emerge Synergistic Anti-tumor Effect on Canine Breast Cancer by Inducing Apoptosis via Mitochondrial Pathway

  2021cites this paper
• [Potential Anticancer Activity of Auranofin].

  2021cites this paper
• Auranofin prevents liver fibrosis by system Xc-mediated inhibition of NLRP3 inflammasome

  2021cites this paper
• Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer

  2021cites this paper
• Auranofin prevents liver fibrosis by system Xc-mediated inhibition of NLRP3 inflammasome

  2021cites this paper
• Au2phen and Auoxo6, Two Dinuclear Oxo-Bridged Gold(III) Compounds, Induce Apoptotic Signaling in Human Ovarian A2780 Cancer Cells

  2021cites this paper
• Chemistry of Gold

  2021cites this paper
• Gold Cluster Capped with a BCL-2 Antagonistic Peptide Exerts Synergistic Antitumor Activity in Chronic Lymphocytic Leukemia Cells.

  2021cites this paper
• Deubiquitinases in hematological malignancies

  2021cites this paper
• Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer

  2021cites this paper
• Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin

  2021cites this paper
• The double-edged roles of ROS in cancer prevention and therapy

  2021cites this paper
• NMR reveals the metabolic changes induced by auranofin in A2780 cancer cells: evidence for glutathione dysregulation.

  2021cites this paper
• Targeting translation: a promising strategy for anticancer metallodrugs

  2021cites this paper
• Cell death mechanisms—Apoptosis pathways and their implications in toxicology

  2020cites this paper
• Redox regulation of immunometabolism

  2020cites this paper
• An anticancer gold(III)-activated porphyrin scaffold that covalently modifies protein cysteine thiols

  2020cites this paper
• Analysis of retrotransposon subfamily DNA methylation reveals novel early epigenetic changes in chronic lymphocytic leukemia

  2020influential citation
• Clinical trials on combination of repurposed drugs and anticancer therapies

  2020cites this paper
• Combined treatment with auranofin and trametinib induces synergistic apoptosis in breast cancer cells

  2020cites this paper
• ROS Overproduction Sensitises Myeloma Cells to Bortezomib-Induced Apoptosis and Alleviates Tumour Microenvironment-Mediated Cell Resistance

  2020cites this paper
• Reactions of Medicinal Gold(III) Compounds With Proteins and Peptides Explored by Electrospray Ionization Mass Spectrometry and Complementary Biophysical Methods

  2020cites this paper
• TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral Activity

  2020influential citation
• Repurposing Auranofin and Evaluation of a New Gold(I) Compound for the Search of Treatment of Human and Cattle Parasitic Diseases: From Protozoa to Helminth Infections

  2020cites this paper
• Cancer cell-selective modulation of mitochondrial respiration and metabolism by potent organogold(iii) dithiocarbamates†

  2020cites this paper
• Deubiquitinases: Pro-oncogenic Activity and Therapeutic Targeting in Blood Malignancies.

  2020cites this paper
• Synthesis, characterization, DFT optimization and anticancer evaluation of phosphanegold(I) dithiocarbamates

  2020cites this paper